📊 CRWV (CoreWeave) – Technical Outlook & Options Play
CRWV is showing signs of strength after breaking out of a descending channel. Volume spikes confirm accumulation, and price is approaching equilibrium levels.
Support Zone: $110–$120
Immediate Resistance: $140–$150 supply zone
Breakout Target: $160+ (Fibonacci extension & institutional models align)
Forecast Models:
Institutional-grade forecast → Target $161.61 (+27.6%) within 15 days
WaverVanir DSS model → $176.98 (15D) / $278.66 (30D) if momentum sustains
📌 Options Position:
I bought CRWV $150 Calls exp. 10/3 at $1.90. Breakeven: $151.90. Risk capped at premium.
⚠️ Watchouts:
Must clear $140–$150 zone with volume.
IV crush risk into expiration.
💡 Thesis: If CRWV reclaims $150+ on momentum, this can run toward $160–$175 short-term. Longer horizon models even suggest $250–$275 if momentum compounds.
🔗 #CRWV #OptionsTrading #AI #TechStocks #TradingView #Breakout
CRWV is showing signs of strength after breaking out of a descending channel. Volume spikes confirm accumulation, and price is approaching equilibrium levels.
Support Zone: $110–$120
Immediate Resistance: $140–$150 supply zone
Breakout Target: $160+ (Fibonacci extension & institutional models align)
Forecast Models:
Institutional-grade forecast → Target $161.61 (+27.6%) within 15 days
WaverVanir DSS model → $176.98 (15D) / $278.66 (30D) if momentum sustains
📌 Options Position:
I bought CRWV $150 Calls exp. 10/3 at $1.90. Breakeven: $151.90. Risk capped at premium.
⚠️ Watchouts:
Must clear $140–$150 zone with volume.
IV crush risk into expiration.
💡 Thesis: If CRWV reclaims $150+ on momentum, this can run toward $160–$175 short-term. Longer horizon models even suggest $250–$275 if momentum compounds.
🔗 #CRWV #OptionsTrading #AI #TechStocks #TradingView #Breakout
Note
Trade active
Trade closed manually
124 didn't hold
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.